Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)

China · Delayed Price · Currency is CNY

20.00

-0.20 (-0.99%)

Oct 22, 2026, 4:00 PM EDT

Market Cap	8.22B -26.4%
Revenue (ttm)	1.36B -9.4%
Net Income	42.78M -82.5%
EPS	0.10 -82.8%
Shares Out	410.81M
PE Ratio	194.51
Forward PE	44.44
Dividend	0.10 (0.50%)
Ex-Dividend Date	Jun 3, 2026

Volume	1,187,750
Open	20.26
Previous Close	20.20
Day's Range	20.00 - 20.29
52-Week Range	18.91 - 28.43
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHA:688739

Liaoning Chengda Biotechnology Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of vaccines in China and internationally. It offers inactivated Japanese encephalitis and SPEEDA-rabies vaccines. The company also develops rabies vaccine which is in new drug approval stage; influenza vaccine which is in new drug application stage; recombinant human papillomavirus 15-valent vaccine which is in Phase II clinical stage; and 13-valent pneumococcal polysaccharide conjugate, varicella, and meningococcal ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 1,585

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688739

Full Company Profile

Financial Performance

In 2025, SHA:688739's revenue was 1.39 billion, a decrease of -17.06% compared to the previous year's 1.68 billion. Earnings were 131.79 million, a decrease of -61.56%.

Financial Statements